yingweiwo

17β-HSD

17β-HSD

17β-HSD related products

Structure Cat No. Product Name CAS No. Product Description
17β-HSD5 inhibitor 3 V87260 17β-HSD5 inhibitor 3 948581-46-2 17β-HSD5 inhibitor 3 (Compound 31) is an orally active 17β-HSD5 inhibitor with IC50 of 69 nM.
3-Acetyl-7-Hydroxycoumarin V107007 3-Acetyl-7-Hydroxycoumarin 10441-27-7 3-Acetyl-7-hydroxycoumarin (Compound 2) is a highly selective 17-β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitor.
ESC1002755 V135250 ESC1002755 2915567-21-2 ESC1002755 is a 17β-HSD10 inhibitor with an IC50 of 19 nM.
Gatuzosiran sodium V116796 Gatuzosiran sodium Gatuzosiran sodium is an siRNA that inhibits the synthesis of 17-β-hydroxysteroid dehydrogenase 13 (HSD17B13) and is used in research on fatty liver disease.
GPI2A sodium scrambled negative control V136859 GPI2A sodium scrambled negative control The GPI2A sodium scrambled negative control is a negative control with the GPI2A sodium ion sequence scrambled.
HSD17B13-IN-105 V137585 HSD17B13-IN-105 3012624-88-0 HSD17B13-IN-105 is a selective 17β-hydroxysteroid dehydrogenase 13 (17BHSD13) inhibitor with an IC50 value of 0.036 μM and high selectivity for 17BHSD4 (IC50 value of 31.5 μM).
HSD17B13-IN-13 V83887 HSD17B13-IN-13 2762668-28-8
HSD17B13-IN-20 V83902 HSD17B13-IN-20 2919797-59-2
HSD17B13-IN-21 V83951 HSD17B13-IN-21 2758802-18-3
HSD17B13-IN-32 V83936 HSD17B13-IN-32 2770246-61-0
HSD17B13-IN-43 V84153 HSD17B13-IN-43 2770246-11-0
HSD17B13-IN-49 V83966 HSD17B13-IN-49 2770246-74-5
HSD17B13-IN-58 V84149 HSD17B13-IN-58 2770246-89-2
HSD17B13-IN-80-d2 V83831 HSD17B13-IN-80-d2 2770247-90-8
HSD17B13-IN-86 V83878 HSD17B13-IN-86 2770247-78-2
HSD17B13-IN-93 V83921 HSD17B13-IN-93 2848620-87-9
Rapirosiran sodium scrambled negative control V143845 Rapirosiran sodium scrambled negative control The Rapirosiran sodium scrambled negative control is a negative control with the sequence of Rapirosiran sodium scrambled.
Contact Us